Vystar to Produce RxAir400 UV-C Light Air Purifiers with New Manufacturer
16 juil. 2020 09h07 HE
|
Vystar Corp.
CDC reports UV-C Light Germicidal Irradiation (UVGI) as one of “most promising methods" for Coronavirus decontamination of facemasks.1 RxAir400 employs powerful UVGI proven to inactivate >99.9% of...
InductiveHealth Appoints Alexis Sulyma as New Chief Growth Officer
13 juil. 2020 12h06 HE
|
InductiveHealth Informatics
ATLANTA, July 13, 2020 (GLOBE NEWSWIRE) -- InductiveHealth Informatics (InductiveHealth), a public health technology firm known for bringing innovation to the public health informatics industry and...
Innovation Pharmaceuticals – Clinical Trial Testing of Brilacidin Against SARS-CoV-2 (COVID-19) Targeted to Commence Q4 2020
13 juil. 2020 08h00 HE
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., July 13, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today provides perspectives on the planned...
In Vitro Testing of Innovation Pharmaceuticals’ Brilacidin for COVID-19 Shows Consistent Anti-SARS-CoV-2 Efficacy; Manufacturing Preparation Underway for COVID-19 Clinical Trial
07 juil. 2020 08h00 HE
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., July 07, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today reports the latest developments related...
Innovation Pharmaceuticals’ Brilacidin Inhibits SARS-CoV-2 (COVID-19) by 97 Percent in a Human Lung Cell Line
17 juin 2020 07h30 HE
|
Innovation Pharmaceuticals Inc.
Data From Ongoing Testing at U.S. Regional Biocontainment Laboratory Data adds to growing body of research in both human and animal cell lines supporting Brilacidin’s robust antiviral properties...
Innovation Pharmaceuticals Collaborating with Regional Biocontainment Lab on Grant Application to Research Brilacidin as a Pan-Coronavirus Therapeutic
11 juin 2020 07h30 HE
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., June 11, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announces today the Company and researchers...
Vystar Resumes Production of FDA Certified Rx3000 UV Light Air Purifiers for Use in Healthcare Facilities
07 mai 2020 09h00 HE
|
Vystar Corp.
Rx3000® UV Light Air Purifier production shifts to Massachusetts to ensure quality, fast production & delivery Rx3000 inactivates on first pass 99.97% of harmful airborne viruses & bacteria. ...
Hire Heroes USA Announces Partnership with CDC Foundation
05 mai 2020 08h00 HE
|
Hire Heroes USA
ALPHARETTA, GEORGIA, May 05, 2020 (GLOBE NEWSWIRE) -- Hire Heroes USA, the nation’s leading employment nonprofit for veterans and military spouses, announces their partnership with the CDC...
Husson University Planning for Fall Reopening
01 mai 2020 07h00 HE
|
Husson University
BANGOR, MAINE, May 01, 2020 (GLOBE NEWSWIRE) -- Husson University announced today that it is preparing to welcome students back to campus when the fall semester resumes on August 31, 2020 with an...
Innovation Pharmaceuticals Informed Next Phase of Brilacidin Coronavirus (COVID-19) Testing to Begin Week of May 4
27 avr. 2020 09h30 HE
|
Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., April 27, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report the Company has been...